S4
SN38&ICG were calculated by the equations below: 
Where WFed represents the initial total mass of added drug; WNon-encapsulated is the unencapsulated drug mass in supernatant after centrifugation; WGd&Yb-LDH represents the total mass of added Gd&Yb-LDH during the drug loading; Wtotal represents the total mass of added Gd&Yb-LDH and encapsulated drug.
Isothermal titration calorimetry (ITC) measurements. ITC measurements were performed
on a Nano ITC (TA Instruments Waters, LLC, UT) in the following procedure: 250 µL of ICG (1.010 3 mol/L) suspension was added dropwise through a calorimeter injection syringe into 1.2 mL of SN38 (1.010 4 mol/L) stored in ITC cell at 25 °C. A full heat equilibration was maintained by setting the titration gap at 300 s. An independent model was performed to obtain titration curves; the thermodynamic parameters (enthalpy change ΔH, entropy change ΔS and affinity constant KA) were obtained by TA Instruments NanoAnalyze TM software. The measurement between SN38&ICG (1.010 4 mol/L) and Gd&Yb-LDH aqueous suspension (1.010 3 mol/L) was carried out in the same process.
Photothermal effect of SN38&ICG/Gd&Yb-LDH. To detect the temperature variation, 1.0 mL of SN38&ICG/Gd&Yb-LDH (2.5 μg/mL), ICG (2.5 μg/mL), and PBS were placed in a 1.5 mL of glass vial, respectively. The temperature change was monitored using a thermal infrared imaging camera (Fluke Ti450, USA) with NIR laser irradiation (808 nm fiber-coupled semiconductor diode, 1 W/cm 2 ) at the bottom of vial. At the same time, thermal S5 infrared images were recorded at different time points. The photothermal performance under other conditions was carried out by the same method.
pH and photo-stimulated release of SN38 from SN38&ICG/Gd&Yb-LDH. The pH of SN38&ICG/Gd&Yb-LDH (2.5 μg/mL) suspension was adjusted to 5.5, 6.5 and 7.4, respectively, followed by continues irradiation (808 nm, 1.0 W/cm 2 ) for 3 min. The released SN38 in the supernatant was separated by centrifugation and quantified via UV-vis absorption at 370 nm. The fluorescence spectra and photographs under UV irradiation were recorded as well.
Detection of singlet oxygen production. 1,3-diphenylisobenzofuran (DPBF) was used as a probe to detect singlet oxygen production. Briefly, A DPBF acetonitrile solution (20 μL, 70 µM) was added into 2 mL of ICG or SN38&ICG/LDH suspension (ICG equivalent concentration: 2.5 μg/ml), respectively. The mixed suspension was irradiated by an 808 nm laser irradiation (1.0 W/cm 2 ) for 8 min and the UV-vis absorption spectra were monitored every minute. The singlet oxygen production efficiency is proportional to the decrease rate of DPBF absorption intensity at 410 nm.
Cell line and culture. Hela cells were obtained from Institute of Basic Medical Sciences
Chinese Academy of Medical Sciences (Beijing, China). Cells were incubated in a 25 cm 2 cell-culture flask and cultured well in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin in an atmosphere of 5% CO2 at 37 °C. After cells spread over 80% of the bottom, 1.0 mL of trypsin (0.25%) was added to detach cells (23 min) followed by adding 2 mL of DMEM to terminate digestion.
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In vitro fluorescence image. Hela cells were trypsinized and expanded on confocal dishes (35 mm) in an incubator for 24 h (37 °C; 5% CO2). Afterwards, cells were incubated with SN38&ICG/Gd&Yb-LDH suspension (5 μg/mL, 2 mL) for 6 h. After incubation, the cells were washed thoroughly with sterile PBS for 3 times, and Hoechst 33342 (10 µg/mL, 2 mL) was added to stain nuclei of cells. After 10 min, cells were washed with PBS again for 3
times. Finally, images were obtained using a Leica confocal laser scanning microscopy (Leica, Germany). 
In vitro
In addition, cells were stained with Calcein-AM/PI to visualize the population of viable and necrotic cells. The mode of cell death was determined using an annexin V-FITC and PI staining kit according to the manufacturer's instructions.
Calculation of combination index (CI). In a certain drug combination, CI is usually
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calculated to evaluate the synergetic effect of drugs. In this work, the synergistic effect in this chemo/PTT/PDT tri-mode therapy was achieved through the combination of SN38 and ICG, so CI value was used to reveal the effect of tri-mode therapy compared with the sum of each treatment. CI is calculated by the following formula:
where D1 and D2 are the concentrations of drug 1 and drug 2 that in combination to produce certain amount of cell inhibition (e.g., 50%); while Dm1 and Dm2 represent the concentrations of these drugs administered alone to induce the same cellular cytotoxicity. CI value significantly lower than 1.0 indicates synergism; CI value higher than 1.0 represents antagonism; CI value equal to 1.0 represents additivity. 
Relative tumor volume was calculated as V/V0 (V and V0 are the tumor volume measured at S9 time t and t0, respectively).
Histology examination. On day 16, the mice were euthanized, and tumors as well as main organs were collected and fixed in 4% formalin for histology analysis. All the tissues were sliced to 35 mm for hematoxylin and eosin (H&E) staining and examined by a digital microscope (Leica).
Computational methods. The geometry optimizations of SN38 and ICG were performed at The process of anneal and dynamics were performed using Forcite module in Materials Studio (MS) 3 software with Universal Force Field (UFF) 4 . The temperature and pressure were controlled using the Andersen and Berendsen method, respectively. The long-range coulombic interactions were computed by the Ewald summation technique, and the van der Waals interactions were calculated using the "spline-cutoff" method. The MD time step was set to 1 fs. 10 ps simulated annealing was taken to obtain stable structures of the complexes at the experimental temperatures in isothermal-isobaric ensemble. 
where D is diffusion coefficient; () i rt is the location of particle i at time t ; 0 (0) r represents the initial position.
Statistical analysis. Data were expressed as mean ± standard deviation. The significant differences among groups were determined using one-way ANOVA analysis followed by Tukey's post-test: (*) P < 0.05, (**) P < 0.01 and (***) P < 0.001.
Sample characterization. Shimadzu XRD-6000 diffractometer with a Cu Kα source was used to recorded powder X-ray diffraction patterns, with a scan step of 0.02° and a scan range between 3° and 70°. For colloid LDH samples, XRD tests were performed by dripping a droplet of colloid LDH sample onto a silicon wafer, which was then covered by a PET film.
In addition, the control sample was obtained by drying the above colloid LDH sample on WFed represents the initial total mass of added drug; WNon-encapsulated is the unencapsulated drug mass in supernatant after centrifugation; WGd&Yb-LDH represents the total mass of added Gd&Yb-LDH during the drug loading; Wtotal represents the total mass of added Gd&Yb-LDH and encapsulated drug. and Hela cells incubated with 500 μg/mL of Gd&Yb-LDH nanosheets. 
